Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Joao Paulo Mattos Almeida"'
Autor:
Adam Yuh Lin, Joao Paulo Mattos Almeida, Adham Bear, Nathan Liu, Laureen Luo, Aaron Edward Foster, Rebekah Anna Drezek
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63550 (2013)
Gold nanoparticle accumulation in immune cells has commonly been viewed as a side effect for cancer therapeutic delivery; however, this phenomenon can be utilized for developing gold nanoparticle mediated immunotherapy. Here, we conjugated a modified
Externí odkaz:
https://doaj.org/article/53119f93fc4143afa1469dc6118621b4
Autor:
Adham S Bear, Laura C Kennedy, Joseph K Young, Serena K Perna, Joao Paulo Mattos Almeida, Adam Y Lin, Phillip C Eckels, Rebekah A Drezek, Aaron E Foster
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e69073 (2013)
Ablative treatments such as photothermal therapy (PTT) are attractive anticancer strategies because they debulk accessible tumor sites while simultaneously priming antitumor immune responses. However, the immune response following thermal ablation is
Externí odkaz:
https://doaj.org/article/5669772c71314b089987371bba19e559
Autor:
Aaron E. Foster, Joao Paulo Mattos Almeida, Adam Yuh Lin, Elizabeth R. Figueroa, Rebekah A. Drezek
Publikováno v:
Small. 11:1453-1459
Gold nanoparticles (AuNPs) are promising vehicles for cancer immunotherapy, with demonstrated efficacy in immune delivery and innate cell stimulation. Nevertheless, their potential has yet to be assessed in the in vivo application of peptide cancer v
Autor:
Aaron E. Foster, Adam Yuh Lin, Rebekah A. Drezek, Joao Paulo Mattos Almeida, Phillip C. Eckels, Robert J Langsner
Publikováno v:
Small. 10:812-819
Gold nanoparticles (AuNP) have been widely used for drug delivery and have recently been explored for applications in cancer immunotherapy. Although AuNPs are known to accumulate heavily in the spleen, the particle distribution within immune cells ha
Publikováno v:
Immunotherapy. 6(2)
Although substantial progress has been made in developing treatments for primary tumors, the main challenge in cancer therapy remains the treatment of metastatic disease. Importantly, a number of primary treatment modalities have been shown to induce
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine. 10(3)
Significant progress has been made in the field of cancer immunotherapy, where the goal is to activate or modulate the body's immune response against cancer. However, current immunotherapy approaches exhibit limitations of safety and efficacy due to
Publikováno v:
Nanomedicine (London, England). 6(5)
Nanoparticles have potential applications in diagnostics, imaging, gene and drug delivery and other types of therapy. Iron oxide nanoparticles, gold nanoparticles and quantum dots have all generated substantial interest and their properties and appli